NCT03174223View on ClinicalTrials.gov

Influence of Deep Versus Moderate Neuromuscular Blockade During General Anesthesia on 30-day Readmission Rates

CompletedOBSERVATIONAL

Enrollment

460

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

June 1, 2018

Study Completion Date

July 1, 2018

Conditions

Postoperative ComplicationsPostoperative Wound InfectionPneumonia

Interventions

DRUG

deep neuromuscular block

a continuous dosing of rocuronium is used to achieve neuromuscular block of 1-2 twitches post tetanic count

Trial Locations (1)

2333ZA

Leiden University Medical Center, Leiden

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Leiden University Medical Center

OTHER

NCT03174223 - Influence of Deep Versus Moderate Neuromuscular Blockade During General Anesthesia on 30-day Readmission Rates | Biotech Hunter | Biotech Hunter